The impact of patient travel time on disparities in treatment for early stage lung cancer in California.

The impact of patient travel time on disparities in treatment for early stage lung cancer in California.

Show other versions (1)

<h4>Background</h4>Travel time to treatment facilities may impede the receipt of guideline-concordant treatment (GCT) among patients diagnosed with early-stage non-small cell lung cancer (ES-NSCLC). We investigated the relative contribution of travel time in the receipt of GCT among ES-N...

Full description

Bibliographic Details
Main Authors: Chelsea A Obrochta, Humberto Parada, James D Murphy, Atsushi Nara, Dennis Trinidad, Maria Rosario Happy Araneta, Caroline A Thompson
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0272076

Internet

https://doi.org/10.1371/journal.pone.0272076

Similar Items